Systematic review: the management of hepatic cyst infection

M A Lantinga1, A Geudens, T J G Gevers

  • 1Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, the Netherlands.

Insights

Hepatic cyst infection treatment is highly variable. Oral ciprofloxacin is recommended initially, with percutaneous drainage considered for treatment failures. Recurrence is common, especially in transplant recipients.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Surgical Gastroenterology

Background:

  • Hepatic cyst infection is a serious complication of hepatic cystic disease.
  • Current treatment strategies lack evidence-based guidelines.

Purpose of the Study:

  • To systematically review and synthesize evidence on treatment strategies for de novo hepatic cyst infection.
  • To provide evidence-based treatment recommendations.

Main Methods:

  • Systematic literature search of PubMed, EMBASE, and Cochrane Library (up to 2014).
  • Inclusion of human studies (≥18 years) on hepatic cyst infection treatment.
  • Data extraction on patient demographics, treatments, and outcomes.

Main Results:

  • Analysis of 54 cases from 41 case series/reports, indicating high bias.
  • Initial treatments included antimicrobials (56%), percutaneous drainage (31%), and surgery (13%).
  • Antimicrobial failure occurred in 70%, necessitating further intervention; recurrence rates were 20%, with higher incidence in renal transplant recipients.

Conclusions:

  • Hepatic cyst infection treatment is highly heterogeneous.
  • Recommend oral ciprofloxacin as first-line therapy.
  • Percutaneous cyst drainage is advised for treatment failures.
Abstract

Related Concept Videos

Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
1.3K
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
541
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
656
Cholecystitis01:20

Cholecystitis

Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
20
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
1.2K
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
763